Biodegradation of venlafaxine (LB289)

Alleviation of erythromelalgia with venlafaxine.

Venlafaxine and reversible blepharoedema.

The newer antidepressant venlafaxine is known to cause dilutional hyponatraemia, but to our knowledge no reports on localized oedemas in the absence of electrolyte disturbances are available. We present a case in which venlafaxine caused reversible blepharoedema in an otherwise physically healthy patient. Ms. M., a 25-yr-old women, suffered from schizoaffective disorder since being 23 years old...

Venlafaxine-induced Mania

Venlafaxine is a novel antidepressant with a rapid onset of action. It is highly efficacious in the treatment of depression and in comparison to the traditional thcyclic antidepressants, it has a favourable side effects profile. Although effective, venlafaxine too carries a risk for manic switch in bipolar affective disorder patients. Give the paucity of literature, we report a case of venlafax...

Venlafaxine besylate monohydrate

The title compound {systematic name: [2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl]dimethylazanium benzene-sulfonate monohydrate}, C17H28NO2 (+)·C6H5O3S(-)·H2O, is a besylate salt hydrate of the anti-depressant drug venlafaxine. In the crystal, besylate anions and water mol-ecules self-assemble, forming hydrogen-bonded dimers linked around inversion centers, with graph set R 4 (4)(6). The c...

Venlafaxine and bladder function.

BACKGROUND Occasional case reports describe urinary incontinence in patients taking the selective serotonin and norepinephrine reuptake inhibitor antidepressant venlafaxine. OBJECTIVE In this study the authors investigated the possible effect of venlafaxine on urinary function in a series of 9 patients with urinary retention resulting from spinal cord lesions. They primarily sought to underst...